Journey Medical (DERM) Shares Outstanding (2020 - 2026)
Journey Medical's (DERM) quarterly Shares Outstanding (Entity) came in at $27.3 million in Q1 2026, up 20.76% YoY from $22.6 million in Q1 2025, and up 29.13% on a QoQ basis from $21.1 million in Q4 2025.
Journey Medical (DERM) Shares Outstanding (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Shares Outstanding (Entity) data on file, last reported at $27.3 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 20.76% year-over-year to $27.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.3 million (up 20.76% YoY) and the FY2025 annual result came in at $21.1 million, up 3.49% from the prior year.
- Shares Outstanding (Entity) climbed to $27.3 million in Q1 2026, from $21.1 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $27.3 million in Q1 2026 to a low of $17.3 million in Q1 2022.
- A 5-year average of $19.9 million and a median of $19.8 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) surged 92.31% — and 2025, when it decreased 0.8%.
- Tracing DERM's Shares Outstanding (Entity) over 5 years: stood at $17.5 million in 2022, then increased by 4.0% to $18.2 million in 2023, then grew by 12.06% to $20.4 million in 2024, then grew by 3.49% to $21.1 million in 2025, then grew by 29.13% to $27.3 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $27.3 million (Q1 2026), $21.1 million (Q4 2025), and $20.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 832.44 Mn |
| 10 | Journey Medical | 205.65 Mn | 180.01 Mn | 12.37 Mn | 27.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.31 Mn |
| Mar 31, 2026 | 27.31 Mn |
| Dec 31, 2025 | 24.50 Mn |
| Sep 30, 2025 | 24.96 Mn |
| Jun 30, 2025 | 23.29 Mn |
| Mar 31, 2025 | 22.61 Mn |
| Dec 31, 2024 | 20.43 Mn |
| Sep 30, 2024 | 20.54 Mn |
| Jun 30, 2024 | 19.99 Mn |
| Mar 31, 2024 | 19.76 Mn |
| Dec 31, 2023 | 18.23 Mn |
| Sep 30, 2023 | 18.42 Mn |
| Jun 30, 2023 | 18.01 Mn |
| Mar 31, 2023 | 17.81 Mn |
| Dec 31, 2022 | 17.53 Mn |
| Sep 30, 2022 | 17.62 Mn |
| Jun 30, 2022 | 17.46 Mn |
| Mar 31, 2022 | 17.32 Mn |
| Dec 31, 2021 | 10.19 Mn |
| Sep 30, 2021 | 9.16 Mn |